The Effect on Depressive Symptoms in ECF Residents With COPD

Completed · Phase 4

Conditions studied: Chronic Obstructive Pulmonary Disease, Depression

In brief

The purpose of this study is to assess the effect of treatment with Advair Diskus on depression using the Cornell depression scale in COPD patients in the nursing home.

Key facts

Study ID

NCT00974246

Run by

Valley Medical Research

People needed

30

Starts

2009-10-01

Expected to finish

2011-07-01

Last updated by the study team

2016-12-28

Who can join

Age: 18 and older, up to 94. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult men and women nursing home residents up to age 95
• Stated diagnosis of COPD or FEV1/FVC <0.7 or being treated with an anticholinergic
• Presence of depressive symptoms as measured on MDS 3.0 Section D SUM
• Free from conditions likely to be fatal within six months
• Able to read or understand English
• Able and willing to provide informed consent or has a guardian/LAR who can provide informed consent

You may not qualify if…

• Currently pregnant
• Unable to read and understand English
• Free from conditions likely to be fatal within six months
• Enrolled in hospice
• New treatment with antidepressant within the last 90 days.
• Current or recent use (within the last 90 days) of Advair Diskus
• Unwilling or unable to provide informed consent
• Expected to be discharged within 3 months

Where it is running

• Geriatric Medical Associates — Brooksville, Florida, United States
• Valley Medical Research — Centerville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.